Pharmacokinetics of progesterone a few other countries under the brand name Progestasert. It was marketed between 1976 and 2001. The IUD was never widely used due to a relatively high contraceptive failure rate of 2.9% and the requirement of annual replacement. It contained 38 mg progesterone and released 65 μg progesterone into the uterus per day (adding up to about 35 mg after one year). For comparison, a woman's body produces on average about 25 mg progesterone per day during the luteal phase. While effective as a form of contraception and for decreasing menstrual bleeding and discomfort, long-lived IUDs can fundamentally only deliver
Pharmacokinetics of progesterone of the menstrual cycle with LC–MS/MS are 6.7 to 22.2 ng/mL. When the unreliable method of standalone RIA has been used to measure progesterone levels with oral progesterone, far higher peak levels of 6.5 to 10.2 ng/mL, 13.8 to 19.9 ng/mL, and 32.3 to 49.8 ng/mL have been erroneously observed after single 100, 200, and 300 mg doses, respectively. In addition, progesterone levels have been inaccurately measured by RIA as remaining elevated for 12 to 24 hours. Regardless of assay method, peak levels of progesterone following a dose of oral progesterone occur after about 1 to 3 hours. The elimination